Skip to main content
. 2020 Dec 8;7:607821. doi: 10.3389/fmed.2020.607821

Figure 3.

Figure 3

Success curves of HFNC therapy in patients from HFNC onset to termination according to different levels of score. (A) Training cohort; (B) validation cohort; For HFNC failure in hospital: weighted score 0–6 = low risk; ≥6 = high risk. HFNC, high-flow nasal cannula.